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Background and purpose: The aim of the study was to determine the effectiveness of percu-
taneous balloon kyphoplasty for treatment of compressive vertebral fractures.
Materials and methods: A retrospective analysis was conducted on 24 patients with 58
symptomatic vertebral fractures treated by balloon kyphoplasty. Visual Analogue Pain Scale
(VAS) and Oswestry Disability Index (ODI) were used to assess fracture-related pain and
patient's disability: preoperatively and within 12-months follow-up. Following the proce-
dures to evaluate the change of vertebral deformity, the angle of local kyphosis was
measured.
Results: Preoperative VAS score was 6.54, at discharge it signiﬁcantly regressed in 95.8% of
patients. The overall VAS score at discharge was 1.25 and within 12 months decreased to
0.26. Preoperative ODI score was 50%, at follows-up in all patients it decreased, ranging from
21% to 10%. Reduction of local kyphosis was achieved in 30 (51.7%) vertebrae by average 4.38.
In 9 (37.5%) patients kyphosis of all augmented vertebrae was reduced, in 7 (29.2%) patients
procedures reduced kyphosis in part of augmented vertebrae and in 8 patients (33.3%)
kyphosis remained unchanged. Asymptomatic complications included cement leak in 10
(17%) vertebrae and intraoperative rupture of 4 (4%) balloons.
Conclusions: Rapid signiﬁcant pain relief after kyphoplasty followed by long-term pain
release and disability reduction obtained in all patients was most probably the result of
vertebral augmentation. The correction of local kyphosis had no inﬂuence on the outcome.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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There are two minimally invasive percutaneous methods:
vertebroplasty and balloon kyphoplasty (BKP), which are
widely used for augmentation of vertebrae. The accepted
indications for their use include osteoporotic vertebral
fractures, spinal myeloma, metastases and haemangiomas
[1–5]. In 1987, vertebroplasty was ﬁrst described as injection of
bone cement into vertebral body (VB) causing its mechanical
reinforcement and pain relief [1–4]. Vertebroplasty does not
inﬂate the compressed VB; however, in a fraction of fractured
vertebrae with mobile bony fragments the reduction in
deformity was achieved [2,6]. Percutaneous balloon kypho-
plasty (BKP) was introduced in 1998, aiming to correct the
kyphotic deformity secondary to vertebral fracture [1,3,4]. In
this method two inﬂatable balloons are inserted under
radioﬂuoroscopic guidance into the VB. Balloons are inﬂated
in order to re-expand the VB and to create a void in its
spongious bone, thereafter are deﬂated and removed. In the
next step, the created void is ﬁlled with injectable bone
cement, most commonly polymethylmethacrylate (PMMA),
which consecutively hardens stabilizing the shape of expand-
ed vertebra [1,2,4,5]. After more than a decade of experience,
the clinical beneﬁts as well as radiographical results of BKP
remain debated [4,6–16]. The objective of this study was to
analyse the effects of BKP on correction of local kyphosis, pain
relief and patient's quality of life. To the bests of authors'
knowledge this is the ﬁrst clinical study of BKP in Polish
literature.Table 1 – Clinical data for patients undergoing balloon kyphop
Sex/age [years] T-score/comorbidity F
1. F, 74 3.18 L
2. F, 38 5.2; Anorexia T
3. M, 57 Osteopenia, TS T
4. F, 80 Osteopenia L
5. M, 55 2.12; myeloma T
6. M, 74 3.5; orchiectomy T
7. F, 68 Osteopenia L
8. F, 75 2.81 L
9. M, 41 3.7; MS T
10. F, 77 3.54 L
11. M, 60 Myeloma T
12. M, 69 5.03; MS T
13. F, 67 3.45 T
14. M, 77 2.97 L
15. F, 68 1.92; osteopenia, hypothyroidism, TS T
16. M, 78 Osteopenia, RA, ST T
17. F, 78 2.82 L
18. F, 21 6.8; SLE, ST T
19. F, 84 2.31; osteopenia T
20. F, 73 2.87 L
21. F, 76 3.90 L
22. F, 80 3.66 T
23. F, 65 2.52 T
24. F, 69 3.83 L
Mean: 67 N
F, female; M, male; MS, malabsorption syndrome; NC, no correction; RA
erythematosus; ST, steroidotherapy; TS, tobacco smoker.2. Materials and methods
This retrospective study included 24 patients (16 females, 8
males) treated with BKP between 2005 and 2008 for painful
vertebral compressive fractures (Table 1). The age of partici-
pants ranged from 21 to 84 years (mean: 67). The osteoporosis
was conﬁrmed in 16 patients based on bone mineral density of
the proximal femur, with T-score ranging from 2.52 to 6.80
(mean: 3.74). Osteoporosis was classiﬁed as: postmenopausal
(9 females), senile (1 male), due to malnutrition (1 female
treated for anorexia), linked to coeliac disease and bowel
resection (2 males), steroid-induced (2 females) and due to
testosterone deﬁciency after orchiectomy (1 male). Amongst
remaining patients, osteopenia was diagnosed in six and
myeloma in two. A total of 58 fractured vertebrae (29 thoracic,
29 lumbar) were treated. Fractures were diagnosed by X-ray
ﬁlms, computed tomography (CT) or magnetic resonance
image (MRI) and were classiﬁed according to Magerl et al. [17]
as follows: A1.1 (n = 11), A1.2.1 (n = 41), A1.2.3 (n = 2), A3.1.1
(n = 3) and A3.1.3 (n = 1). Six patients (12 vertebrae) were
treated within 3 weeks of symptoms onset, whereas eighteen
between 1 and 8 months (mean: 2.5). On examination, all
patients presented axial back pain corresponding with the
location of fracture and exacerbating by palpation.
The kyphoplasty procedures were performed by the ﬁrst
author, under general anaesthesia, except two realized under
sedation combined with local anaesthesia. The patients were
placed in prone position, with C-arm installed for biplanar
radioﬂuoroscopic guidance. Kyphon® (Sunnyvale, USA)lasty.
ractured vertebrae Kyphosis reduction [jDaj]
1 NC
5, T6, T8, T10, T11, L1 T5: 28, L1: 58
7 T7: 38
2 L2: 78
4, T6 T4: 28, T6: 58
12, L1, L2, L4 T12: 28, L2: 68, L4: 48
1, L2 L1: 28, L2: 58
3, L4 L3: 58
12, L1 NC
2, L4 NC
11, T12, L1 T12: 38, L1: 28
6 T6: 38
11, T12 T11: 38
2 NC
9, T12 T9: 28, T12: 28
12, L1, L2, L4 NC
2, L3, L4 NC
7–T12 T7: 58, T8: 108, T10: 108, T11: 68, T12: 38
11, L1 NC
2, L5 NC
3 L3: 68
9, T10, T12, L2, L3 T9: 58, T10: 68, L3: 28
8 T8: 58
1, L4 L1: 58, L4: 38
 = 58 Mean: 4.38; SD = 2.28
, rheumatoid arthritis; SD, standard deviation; SLE, systemic lupus
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 1 1 – 1 5 13fabricated the kyphoplasty instruments and bone cement
containing PMMA. Through small incisions the working
cannulas were inserted into 42 vertebrae with a bipedicular
approach and into 16 with unipedicular. Through the working
cannula the drill was advanced to create a tunnel for the
balloon. According to the diameter of the VB, 20-mm or 15-mm
balloons were used, containing 6 ml or 4 ml of liquid,
respectively. The balloons were inserted into the cancellous
bone of the VB and inﬂated manually with radiocontrast
medium. To achieve as much expansion as possible, inﬂation
was carried out until maximum tolerable pressure of 400 psi or
maximum balloon volume, thereafter the balloons were
deﬂated and removed. The void was ﬁlled with the cement,
injected under low pressure. Proportionally to the void
dimensions, the injected volume ranged from 3 ml to
10.5 ml per vertebra (mean: 5.5 ml), standard deviation (SD)
= 1.96. Mean cement volume calculated for thoracic and
lumbar vertebrae was 5.0 ml and 7.0 ml, respectively. The
procedure ended in removal of working cannulas and closure
of their cutaneous entry points by single sutures. Patients were
discharged home the following morning or within 3 days after
procedure. In 22 patients the number of vertebrae augmented
per session ranged from 1 to 6. Two patients were treated in 2
sessions with intervals lasting 6 weeks and 8 weeks, in these
cases the date of last session was established as the beginning
of follow-up.
3. Results
The postoperative course was uneventful, repeated fractures
were not diagnosed at follow-up. Pain intensity and quality of
life were assessed preoperatively, at the day of discharge (pain
only) and at follows-up taking place 1 month, 3 months, 6
months and 12 months after kyphoplasty. Five (20.8%) patients
were lost from last follow-up for different reasons.
Back pain at the level of fracture was assessed with Visual
Analogue Pain Scale (VAS), entailing scores from 0 (no pain at
all) to 10 (worst possible pain). At discharge, complete pain
relief was noted in 14 (58.3%) patients, signiﬁcant pain
reduction to VAS score = 1–4 in 9 (37.5%), whereas 1 patient
declared only 1-point decrease of VAS score. Overall mean VAS
pain score decreased from preoperative value 6.54 to 1.25 at
discharge and within 12 months its value diminished to 0.26
(Table 2).Table 2 – Evaluation of pain (VAS score) and quality of life (OD
Baseline Discharge 1 mo
Patients 24 24 24 
VAS mean score 6.54 1.25 1.4
VAS score range 2–10 0–8 0–6
SD 2.431 1.984 1.6
ODI mean score 50% – 21%
ODI score range 8–84% – 0–5
SD 21.580 – 17.6
ODI, Oswestry Disability Index.
VAS, Visual Analogue Pain Scale.
SD, standard deviation.The quality of life was evaluated using Oswestry Disability
Index (ODI) version 1, consisting on ten sections: pain,
personal care, lifting, walking, sitting, standing, sleeping,
sex life, social life and travelling [18]. Patients scored each
section from 0 (best) to 5 (worst), the sum of scores was turned
into percentage of disability. The preoperative mean ODI score
was 50%. At 1-month follow-up the disability of all patients
diminished, the mean ODI was 21% and at consecutive
follows-up it decreased to 10% (Table 2).
Local kyphosis (LK) was deﬁned as angle between superior
and inferior endplates of the fractured vertebra [8,11,16,19]. It
was measured on plain radiographs or CT sagittal reformatted
images obtained preoperatively and after the procedure –
before discharge or at ﬁrst follow-up (Fig. 1). The LK change (Da)
after kyphoplasty was calculated according to following
formula: Da = a2  a1, where a1 and a2 meant LK angle before
and after procedure, respectively; the positive value meant
kyphosis, whereas a negative – lordosis. The reduction of LK
was achieved in 30 (51.7%) vertebrae with the jDaj ranging from
28 to 108 (mean: 4.38). In nine (37.5%) patients BKP reduced LK of
all augmented vertebrae, in seven (29.2%) reduced LK in
fraction of augmented vertebrae, in eight (33.3%) no signiﬁcant
reduction of LK was found (Table 1).
The Mann–Whitney U test revealed no difference between
postoperative ODI and VAS scores in females and males
( p > 0.05). The Kruskal–Wallis test revealed no evidence of
differences between baseline and post procedural VAS scores
in 3 groups of patients: with reduced LK of all augmented
vertebrae, reduced LK in fraction of augmented vertebrae and
those without reduction of LK ( p > 0.05).
Complications related to BKP included leak of PMMA in 10
(17%) vertebrae, belonging to 7 (29%) of patients, none of them
provoked neurologic symptoms. During procedures, 4 (4%)
balloons ruptured, without any damage to patients.
4. Discussion
There is a general consent that BKP corrects vertebral
anatomy, reduces pain and improves patient's quality of life
with lower incidence of extravertebral cement leaks and
clinical complications as compared to vertebroplasty [1–6,9].
However, controversies exist regarding the effectiveness of
BKP in reducing the post-fracture kyphosis and assumed
superiority of BKP over vertebroplasty or conservativeI score).
nth 3 months 6 months 12 months
24 24 19
6 0.92 0.50 0.26
 0–4 0–2 0–3
93 1.176 0.722 0.733
 16% 12% 10%
0% 0–48% 0–44% 0–32%
95 12.956 12.200 10.088
Fig. 1 – Illustration of local kyphosis measurement in the midsagittal plane on reformatted CT scans (Case 8, L3 vertebral body
fracture type A1.2.1). The wedge angle between superior and inferior endplates of the fractured vertebra was measured. (A)
CT scan obtained before procedure (local kyphosis = 58). (B) CT scan obtained 2 days after kyphoplasty (local kyphosis = 08).
Local kyphosis reduction jDaj = 58.
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69 clinical studies and estimated that BKP failed to restore the
kyphotic angle or vertebral height in 34% of vertebrae; also
concluded that mean kyphotic angle restoration of fractures
treated with BKP and of mobile fractures treated with
vertebroplasty was similar, equal to 6.68 [3]. This was later
conﬁrmed by Hiwatashi et al. [9] and Santiago et al. [20], who
pointed out that BKP and vertebroplasty provided the same
degree of vertebral height restoration. Regardless of the
correction of vertebral geometry, the clinical impact of this
radiological result is not known [20]. Lee at al. [11] and Pradhan
et al. [19] revealed that reduction of vertebral kyphosis
obtained with BKP did not signiﬁcantly improve the overall
spinal alignment. In 2005, Feltes et al. observed alleviation of
pain without restoration of VB height [8]. Some authors did not
ﬁnd any association between correction of vertebral deformity
and improvement of pain [12,21,22]. In 2007, groups of experts
published the position statement on percutaneous vertebral
augmentation, concluding that ‘‘the performance of BKP
instead of vertebroplasty may be due to operator experience
or preference’’ [10]. Above-mentioned opinions conﬁrm lack of
evidence-based indications for the use of BKP.
The results presented in this study showed rapid pain relief
of 23 (95.8%) patients with a signiﬁcant decrease of overall
mean VAS pain score by 5.29 points at discharge and with
further improvement within 12 months. The reduction of
disability of all patients came into evidence at a ﬁrst month
follow-up, when the decrease of mean ODI score by 29% was
noted. Within following 11 months the mean ODI ranged
between 16% and 10%, signifying minimal disability. Afore-
mentioned results are conﬁrmed in literature [3,6,7,15,16].
However, in our study clinical outcome shows discrepancy
with radiological results: reduction of LK was achieved in
51.7% of vertebrae, it succeeded in 66.7% of patients; amongst
them only 37.5% had the kyphosis of all fractured vertebrae
reduced. This divergence serves as evidence that clinical
improvement corresponds with intravertebral cement instil-
lation, whereas it is not proportional to the incidence of
deformity correction. The volume of PMMA injected to
vertebrae presumably was the main causative factor of pain
relief, whereas the reduction of LK might play minor
contributing role. The accepted explanation of pain relief
after vertebral augmentation is based upon mechanical effectof cement injected into VB [6,13,23,24]; the contributory role of
heat released during exothermic polymerization of PMMA is
also taken into account [25]. The correlation between amount
of cement injected to VB and clinical results was postulated for
both vertebroplasty and BKP [13,23,24]. The amount of cement
13–16% of VB volume is sufﬁcient to restore its compressive
strength [23]. Nieuvenhuijse et al. revealed that cement
volume equal to 24% of VB volume injected with vertebro-
plasty technique provided optimal pain relief without increase
of complications [24]. Röder et al. estimated for BKP that
cement volumes up to 4.5 ml per vertebra resulted in
signiﬁcant pain relief [13]. Retrospective calculations pre-
sented in this study revealed that vertebrae were augmented
with average cement volume equal to 5.5 ml. It is highly
probable, that higher cement volume provided rapid and long-
term clinical improvement, however, resulted in increased
incidence of extravertebral cement leaks, as compared to
literature [3,15]. This study is limited by lack of control group
and absence of ﬁve patients in the most recent follow-up. In
most patients, one-time postoperative imaging (CT or plain X-
ray ﬁlms) served for measurement of LK, repeated radiologic
examinations were not performed in order to avoid excessive
irradiation of patients and given the lack or recurrent pain at
the treated levels.
5. Conclusions
Rapid signiﬁcant pain relief after kyphoplasty followed by
long-term pain release and disability reduction in all patients
was most probably the result of vertebral augmentation. The
correction of local kyphosis had no inﬂuence on the
outcome.
Conﬂict of interest
None declared.
Financial support
None declared.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 4 9 ( 2 0 1 5 ) 1 1 – 1 5 15Ethics
The work described in this article has been carried out in
accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments involv-
ing humans; EU Directive 2010/63/EU for animal experiments;
Uniform Requirements for manuscripts submitted to Biomed-
ical journals.
r e f e r e n c e s
[1] Garﬁn SR, Hansen AY, Reiley MA. New technologies in
spine. Kyphoplasty and vertebroplasty for the treatment of
painful osteoporotic compression fractures. Spine 2001;26
(14):1511–5.
[2] Mathis JM, Deramond H, Belkoff SM, editors. Percutaneous
vertebroplasty and kyphoplasty. 2nd ed. New York:
Springer Science+Bussiness Media; 2006 [chapter 8].
[3] Hulme PA, Krebs J, Ferguson SJ. Vertebroplasty and
kyphoplasty: a systematic review of 69 clinical studies.
Spine 2006;31(17):1983–2001.
[4] Vaccaro AR, Fehlings MG, Dvorak MF, editors. Spine and
spinal cord trauma. Evidence-base management. 1st ed.
New York: Thieme Medical Publishers; 2011 [chapter 42].
[5] Vaccaro AR, Baron EM, editors. Spine surgery. Operative
techniques. 2nd ed. Philadelphia: Elsevier Saunders; 2012
[chapter 36].
[6] Voggenreiter G. Balloon kyphoplasty is effective in
deformity correction of osteoporotic vertebral compression
fractures. Spine 2005;30(24):2806–12.
[7] Bergmann M, Oberkircher L, Bliemel C. Early clinical outcome
and complications related to balloon kyphoplasty. Orthop
Rev 2012;4(2):e25. http://dx.doi.org/10.4081/or.2012.e25.
[8] Feltes C, Fountas KN, Machinis T. Immediate and early
postoperative pain relief after kyphoplasty without
signiﬁcant restoration of vertebral body height in acute
osteoporotic vertebral fractures. Neurosurg Focus 2005;18
(3):E5.
[9] Hiwatashi A, Westesson P-LA, Yoshiura T. Kyphoplasty and
vertebroplasty produce the same degree of height
restoration. AJNR Am J Neuroradiol 2009;30(4):669–73.
[10] Jensen ME, McGraw JK, Cardella JF. Position statement on
percutaneous vertebral augmentation: a consensus
statement developed by the American Society of
Interventional and Therapeutic Neuroradiology, Society of
Interventional Radiology. American Association of
Neurological Surgeons/Congress of Neurological Surgeons,
and American Society of Spine Radiology. J Vasc Interv
Radiol 2007;18(3):325–30.[11] Lee TO, Jo DJ, Kim SM. Outcome and efﬁcacy of height gain
and sagittal alignment after kyphoplasty of osteoporotic
vertebral compression fractures. J Korean Neurosurg Soc
2007;42(4):271–5.
[12] Papanastassiou ID, Phillips FM, Van Meirhaeghe J.
Comparing effects of kyphoplasty, vertebroplasty, and non-
surgical management in a systematic review of randomized
and non-randomized controlled studies. Eur Spine J 2012;21
(9):1826–43.
[13] Röder C, Boszczyk B, Perler G. Cement volume is the most
important modiﬁable predictor for pain relief in BKP:
results from SWISSspine, a nationwide registry. Eur Spine J
2013;22(10):2241–8.
[14] Schroeder JE, Ecker E, Skelly AC. Cement augmentation in
spinal tumors: a systemic review comparing vertebroplasty
and kyphoplasty. Evid Based Spine Care J 2011;2(4):35–43.
[15] Taylor RS, Fritzell P, Taylor RJ. Balloon kyphoplasty in the
management of vertebral compression fractures: an
updated systematic review and meta-analysis. Eur Spine J
2007;16(8):1085–100.
[16] Van Meirhaeghe J, Bastian L, Boonen S. A randomized trial
of balloon kyphoplasty and nonsurgical management for
treating acute vertebral compression fractures. Spine
2013;38(12):971–83.
[17] Magerl F, Aebi M, Gertzbein SD. A comprehensive
classiﬁcation of thoracic and lumbar injuries. Eur Spine J
1994;3(4):184–201.
[18] Fairbank JCT, Pynsent PB. The Oswestry Disability Index.
Spine 2000;25(22):2940–53.
[19] Pradhan BP, Bae HW, Kropf MA. Kyphoplasty reduction of
osteoporotic vertebral compression fractures: correction of
local kyphosis versus overall sagittal alignment. Spine
2006;31(4):435–41.
[20] Santiago FR, Abela AP, Álvarez LG. Pain and functional
outcome after vertebroplasty and kyphoplasty. Eur J Radiol
2010;75(2):e108–13.
[21] Kasperk C, Hillmeyer J, Nöldge G. Treatment of painful
vertebral fractures by kyphoplasty in patients with primary
osteoporosis: a prospective nonrandomized controlled
study. J Bone Miner Res 2005;20(4):604–12.
[22] Stoffel M, Wolf I, Ringel F. Treatment of painful
osteoporotic compression and burst fractures using
kyphoplasty: a prospective observational design. J
Neurosurg Spine 2007;6(4):313–9.
[23] Boszczyk B. Volume matters: a review of procedural details
of two randomised controlled vertebroplasty trials of 2009.
Eur Spine J 2010;19(11):1837–40.
[24] Nieuwenhuijse MJ, Bollen L, van Erkel AR. Optimal
intravertebral cement volume in percutaneous
vertebroplasty for painful osteoporotic vertebral
compression fractures. Spine 2012;37(20):1747–55.
[25] Belkoff SM, Molloy S. Temperature measurement during
polymerization of polymethylmethacrylate cement used
for vertebroplasty. Spine 2003;28(14):1555–9.
